Abstract:In mammals, the ATM (ataxia-telangiectasia-mutated) and ATR (ATM and Rad3-related) protein kinases function as critical regulators of the cellular DNA damage response. The checkpoint functions of ATR and ATM are mediated, in part, by a pair of checkpoint effector kinases termed Chk1 and Chk2. In mammalian cells, evidence has been presented that Chk1 is devoted to the ATR signaling pathway and is modified by ATR in response to replication inhibition and UV-induced damage, whereas Chk2 functions primarily through ATM in response to ionizing radiation (IR), suggesting that Chk2 and Chk1 might have evolved to channel the DNA damage signal from ATM and ATR, respectively. We demonstrate here that the ATR-Chk1 and ATM-Chk2 pathways are not parallel branches of the DNA damage response pathway but instead show a high degree of cross-talk and connectivity. ATM does in fact signal to Chk1 in response to IR. Phosphorylation of Chk1 on Ser-317 in response to IR is ATM-dependent. We also show that functional NBS1 is required for phosphorylation of Chk1, indicating that NES1 might facilitate the access of Chk1 to ATM at the sites of DNA damage. Abrogation of Chk1 expression by RNA interference resulted in defects in IR-induced S and G2/M phase checkpoints; however, the overexpression of phosphorylation site mutant (S317A, S345A or S317A/S345A double mutant) Chk1 failed to interfere with these checkpoints. Surprisingly, the kinase-dead Chk1 (D130A) also failed to abrogate the S and G2 checkpoint through any obvious dominant negative effect toward endogenous Chk1. Therefore, further studies will be required to assess the contribution made by phosphorylation events to Chk1 regulation. Overall, the data presented in the study challenge the model in which Chk1 only functions downstream from ATR and indicate that ATM does signal to Chk1. In addition, this study also demonstrates that Chk1 is essential for IR-induced inhibition of DNA synthesis and the G2/M checkpoint.

Mammalian Chk2 is a Downstream Effector of the ATM-dependent DNA Damage Checkpoint Pathway

Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent Phosphorylation of Chk1 on Ser-317 in Response to Ionizing Radiation

Cdk-mediated Phosphorylation of Chk1 is Required for Efficient Activation and Full Checkpoint Proficiency in Response to DNA Damage

Targeting Chk2 Kinase: Molecular Interaction Maps and Therapeutic Rationale

Chk1 Regulates the S Phase Checkpoint by Coupling the Physiological Turnover and Ionizing Radiation-Induced Accelerated Proteolysis of Cdc25A.

The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.

Implications for Chk1 Regulation: the 1.7 Å Crystal Structure of Human Cell Cycle Checkpoint Kinase Chk1

Phosphorylation-Dependent Interactions Between Crb2 and Chk1 Are Essential for Dna Damage Checkpoint

Cdk phosphorylation of Chk1 regulates efficient Chk1 activation and multiple checkpoint proficiency

An ATM-independent S-phase Checkpoint Response Involves CHK1 Pathway.

The DNA Damage Effector Chk1 Kinase Regulates Cdc14B Nucleolar Shuttling During Cell Cycle Progression

Phosphorylation of MAD2 at Ser195 Promotes Spindle Checkpoint Defects and Sensitizes Cancer Cells to Radiotherapy in ATM Deficient Cells

Ataxia Telangiectasia Mutated (ATM) Is Dispensable for Endonuclease I-SceI-induced Homologous Recombination in Mouse Embryonic Stem Cells

The Radioresistance to Killing of A1–5 Cells Derives from Activation of the Chk1 Pathway

Drug Discovery Targeting Chk1 and Chk2 Kinases.

Chk2 sustains PLK1 activity in mitosis to ensure proper chromosome segregation

An Overactivated ATR/CHK1 Pathway Is Responsible for the Prolonged G2 Accumulation in Irradiated AT Cells

Chk2 Phosphorylation of BRCA1 Regulates DNA Double-Strand Break Repair

Aurora-B mediated ATM serine 1403 phosphorylation is required for mitotic ATM activation and the spindle checkpoint.

Conformational Change of Human Checkpoint Kinase 1 (Chk1) Induced by DNA Damage

Dual Induction of Apoptosis and Senescence in Cancer Cells by Chk2 Activation: Checkpoint Activation As a Strategy Against Cancer.